R Gupta1, M C Raviglione, M A Espinal. Show Affiliations » 1. World Health Organization.
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/therapeutic useGovernment Programs/trendsHumansInternational CooperationIsoniazid/therapeutic useNational Health Programs/trendsPractice Guidelines as TopicRifampin/therapeutic useTuberculosis, Multidrug-Resistant/drug therapyWorld Health Organization
Substances: See more » Antitubercular AgentsIsoniazidRifampin
Year: 2001 PMID: 11769764
Source DB: PubMed Journal: Int J Tuberc Lung Dis ISSN: 1027-3719 Impact factor: 2.373